|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 50.31 CNY | -0.95% |
|
-2.04% | +0.94% |
| 06-17 | Xingqi Pharmaceutical Begins Phase Three Trial for Anesthetic Gel | MT |
| 05-30 | Xingqi Pharmaceutical Says No Adverse Effects Seen in Phase 1 Eye Drops Trial | MT |
EPS & Dividend: Shenyang Xingqi Pharmaceutical Co.,Ltd.
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Dividend per Share 2 | 0.0456 | 0.0911 | 0.2369 | 0.5466 | 1.888 | 1.071 |
| Rate of return | 0.17% | 0.26% | 0.48% | 1.2% | 2.03% | 2.15% |
| EPS 2 | 0.164 | 0.3936 | 0.8664 | 0.8783 | 0.9847 | 1.379 |
| Distribution rate | 27.8% | 23.1% | 27.3% | 62.2% | 192% | 77.7% |
| Reference price 2 | 26.73 | 34.70 | 49.85 | 45.58 | 93.02 | 49.84 |
| Nbr of stocks (in thousands) | 219,520 | 219,343 | 225,921 | 242,995 | 244,195 | 245,349 |
| Announcement Date | 4/19/20 | 4/19/21 | 4/19/22 | 4/19/23 | 4/18/24 | 4/21/25 |
1CNY in Million2CNY
Estimates
Past dividends: Shenyang Xingqi Pharmaceutical Co.,Ltd.
| 2025-05-21 | Final Payment 1 CNY |
| 2024-10-15 | Interim Payment 0.5 CNY |
| 2024-05-21 | Final Payment 3 CNY |
| 2023-09-21 | Interim Payment 1 CNY |
| 2023-05-21 | Final Payment 1 CNY |
| 2022-09-22 | Interim Payment 0.5 CNY |
| 2022-05-19 | Final Payment 0.4 CNY |
| 2021-09-28 | Interim Payment 0.25 CNY |
| 2021-05-20 | Annual 0.25 CNY |
| 2020-05-20 | Annual 0.125 CNY |
| 2019-06-10 | Annual 0.25 CNY |
| 2018-05-31 | Annual 0.25 CNY |
| 2017-06-20 | Annual 0.125 CNY |
Upcoming events: Shenyang Xingqi Pharmaceutical Co.,Ltd.
| 2025-08-27 | Q2 2025 Earnings Release (Projected) |
| 2025-10-22 | Q3 2025 Earnings Release (Projected) |
| 2026-04-15 | Q4 2025 Earnings Release (Projected) |
| 2026-04-22 | Q1 2026 Earnings Release (Projected) |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
| 2.11% | 2.2% | 15.48x | 1.49x | 2.5x | ||
| 2.42% | 2.5% | 23.27x | 1.49x | 2.24x | ||
| - | - | 11.14x | 8.19x | 5.55x | ||
| 0.47% | 0.47% | 67.23x | 3.71x | 3.38x | ||
| -.--% | 0.05% | 52.81x | 10.76x | 9.82x | ||
| 0.66% | 0.84% | 32.5x | 3.73x | 6.72x | ||
| - | - | -379.76x | - | - | ||
| 2.14% | 2.41% | 11.62x | 1.05x | - | ||
| -.--% | -.--% | 13.14x | -54.24x | 1.64x | ||
| Average | 1.11% | 1.21% | -16.95x | -2.98x | 4.55x | |
| Weighted average by Cap. | 1.8% | 1.88% | 13.00x | 1.64x | 3.35x |
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition